Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zemei Ge

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|June 22, 2017
Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitorsLiqiang Han, Yanzhao Wen, Ridong Li, et al.
European Journal of Medicinal Chemistry|April 9, 2019
Discovery and optimization of thienopyridine derivatives as novel urea transporter inhibitorsYan Zhao, Min Li, Bowen Li, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2018
Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitorsWenjie Zhang, Heyuan Bai, Liqiang Han, et al.
Anti-Cancer Drugs|June 6, 2008
Effect of TM208 on QGY-7703 xenograft tumor growthNing Zhang, Wei Guo, Li Wang, et al.
Journal of Cancer|March 14, 2015
YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt PathwaysBingjie Xue, Wei Huang, Xia Yuan, et al.
The Journal of Organic Chemistry|January 5, 2019
Transition Metal-Free Intermolecular C(sp<sup>2</sup>)-H Direct Amination of Furanones via a Redox PathwayQiang Wei, Junfeng Wang, Eman A Akam, et al.
Bioorganic & Medicinal Chemistry|June 18, 2015
New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compoundsYu Zhang, Bin Liu, Xingyu Wu, et al.
European Journal of Medicinal Chemistry|November 25, 2017
Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activatorsRidong Li, Xianling Ning, Shuo Zhou, et al.
European Journal of Medicinal Chemistry|October 3, 2021
N-(4-acetamidophenyl)-5-acetylfuran-2-carboxamide as a novel orally available diuretic that targets urea transporters with improved PD and PK propertiesShuyuan Wang, Yue Xu, Yan Zhao, et al.
Frontiers in Pharmacology|September 9, 2017
Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer CellsWei Huang, Xia Yuan, Ting Sun, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|June 22, 2017
Synthesis and biological activity of peptide proline-boronic acids as proteasome inhibitorsLiqiang Han, Yanzhao Wen, Ridong Li, et al.
European Journal of Medicinal Chemistry|April 9, 2019
Discovery and optimization of thienopyridine derivatives as novel urea transporter inhibitorsYan Zhao, Min Li, Bowen Li, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2018
Synthesis and biological evaluation of curcumin derivatives modified with α-amino boronic acid as proteasome inhibitorsWenjie Zhang, Heyuan Bai, Liqiang Han, et al.
Anti-Cancer Drugs|June 6, 2008
Effect of TM208 on QGY-7703 xenograft tumor growthNing Zhang, Wei Guo, Li Wang, et al.
Journal of Cancer|March 14, 2015
YSY01A, a Novel Proteasome Inhibitor, Induces Cell Cycle Arrest on G2 Phase in MCF-7 Cells via ERα and PI3K/Akt PathwaysBingjie Xue, Wei Huang, Xia Yuan, et al.
The Journal of Organic Chemistry|January 5, 2019
Transition Metal-Free Intermolecular C(sp<sup>2</sup>)-H Direct Amination of Furanones via a Redox PathwayQiang Wei, Junfeng Wang, Eman A Akam, et al.
Bioorganic & Medicinal Chemistry|June 18, 2015
New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compoundsYu Zhang, Bin Liu, Xingyu Wu, et al.
European Journal of Medicinal Chemistry|November 25, 2017
Discovery and structure-activity relationship of novel 4-hydroxy-thiazolidine-2-thione derivatives as tumor cell specific pyruvate kinase M2 activatorsRidong Li, Xianling Ning, Shuo Zhou, et al.
European Journal of Medicinal Chemistry|October 3, 2021
N-(4-acetamidophenyl)-5-acetylfuran-2-carboxamide as a novel orally available diuretic that targets urea transporters with improved PD and PK propertiesShuyuan Wang, Yue Xu, Yan Zhao, et al.
Frontiers in Pharmacology|September 9, 2017
Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer CellsWei Huang, Xia Yuan, Ting Sun, et al.
Pageof 4